1. Show article details.

    IDEXX (IDXX) Suffers From Macro Headwinds, Cost Constraints

    Benzinga – 1:20 PM ET 08/18/2022

    IDEXX Laboratories suffers from currency fluctuations along with high dependence on third-party distributors. Over the past year, IDEXX has been underperforming its industry with respect to share price movement.

  2. Show article details.

    What's In The Cards For Medtronic (MDT) In Q1 Earnings?

    Benzinga – 1:16 PM ET 08/18/2022

    Medtronic plc is scheduled to report first-quarter and fiscal 2023 results on Aug 23, before the opening bell. In the last reported quarter, the company's earnings lagged the Zacks Consensus Estimate by 2.56%. Medtronic surpassed estimates in three of the trailing four quarters and missed in one, the average surprise being 1.83%. Let's see how things have shaped up prior to this announcement.

  3. Show article details.

    BRIEF-Molina Healthcare Receives Notice Of Intent To Award Mississippi Medicaid Contract

    Reuters – 4:46 PM ET 08/10/2022

    Molina Healthcare Inc (MOH): * MOLINA HEALTHCARE RECEIVES NOTICE OF INTENT TO AWARD MISSISSIPPI MEDICAID CONTRACT. * Molina Healthcare Inc (MOH) - NEW CONTRACT FOR MOLINA'S MISSISSIPPI HEALTH PLAN IS EXPECTED TO BEGIN ON JULY 1, 2023, AND RUN THROUGH JUNE 30, 2027 Source text for Eikon: Further company coverage:

  4. Show article details.

    Molina Healthcare Receives Notice of Intent to Award Mississippi Medicaid Contract

    Business Wire – 4:15 PM ET 08/10/2022

    Molina Healthcare, Inc. (MOH) announced that its Mississippi health plan subsidiary has been notified by the Mississippi Division of Medicaid of its intent to award a Medicaid Coordinated Care Contract for its Mississippi Coordinated Access Program and Mississippi Children’s Health Insurance Program pursuant to the Request for Qualifications issued by DOM on December 10, 2021.

  5. Show article details.

    Analyst Ratings for Molina Healthcare

    Benzinga – 1:32 PM ET 07/29/2022

    Molina Healthcare has observed the following analyst ratings within the last quarter: In the last 3 months, 6 analysts have offered 12-month price targets for Molina Healthcare. Below is a summary of how these 6 analysts rated Molina Healthcare over the past 3 months.

  6. Show article details.

    What 6 Analyst Ratings Have To Say About Molina Healthcare

    Benzinga – 11:34 AM ET 07/29/2022

    Within the last quarter, Molina Healthcare has observed the following analyst ratings: According to 6 analyst offering 12-month price targets in the last 3 months, Molina Healthcare has an average price target of $333.83 with a high of $380.00 and a low of $301.00. Below is a summary of how these 6 analysts rated Molina Healthcare over the past 3 months.

  7. Show article details.

    Recap: Molina Healthcare Q2 Earnings

    Benzinga – 5:58 PM ET 07/27/2022

    Molina Healthcare reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Molina Healthcare beat estimated earnings by 6.06%, reporting an EPS of $4.55 versus an estimate of $4.29. Revenue was up $1.25 billion from the same period last year.

  8. Show article details.

    BRIEF-Molina Healthcare Reports Q2 2022 Financial Results

    Reuters – 5:26 PM ET 07/27/2022

    Molina Healthcare Inc (MOH): * MOLINA HEALTHCARE REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS. * Q2 ADJUSTED EARNINGS PER SHARE $4.99. * Q2 GAAP EARNINGS PER SHARE $4.69. * INCREASES FULL-YEAR 2022 REVENUE AND EARNINGS GUIDANCE. * INCREASED ITS FULL YEAR 2022 PREMIUM REVENUE GUIDANCE TO APPROXIMATELY $30 BILLION.

  9. Show article details.

    Molina Healthcare Reports Second Quarter 2022 Financial Results

    Business Wire – 4:15 PM ET 07/27/2022

    Increases Full-Year 2022 Revenue and Earnings Guidance Molina Healthcare, Inc. (MOH) today reported second quarter 2022 GAAP earnings per diluted share of $4.25 and adjusted earnings per diluted share of $4.55. Financial results are summarized below: Quarter Highlights “We are very pleased with our second quarter and year-to-date performance,” said Joseph Zubretsky, President and Chief Executive Offi...

  10. Show article details.

    Earnings Scheduled For July 27, 2022

    Benzinga – 6:43 AM ET 07/27/2022

      ** Equinor is projected to report earnings for its second quarter. ** Alkermes is estimated to report quarterly earnings at $0.01 per share on revenue of $269.00 million. ** Imperial Ptrl is estimated to report earnings for its second quarter. ** Stifel Financial is projected to report earnings for its second quarter.

  11. Show article details.

    Earnings Scheduled For July 27, 2022

    Benzinga – 4:43 AM ET 07/27/2022

      ** Equinor is projected to report earnings for its second quarter. ** Alkermes is estimated to report quarterly earnings at $0.01 per share on revenue of $269.00 million. ** Imperial Ptrl is estimated to report earnings for its second quarter. ** Stifel Financial is projected to report earnings for its second quarter.

  12. Show article details.

    BRIEF-Molina Healthcare To Acquire My Choice Wisconsin

    Reuters – 4:19 PM ET 07/13/2022

    Molina Healthcare Inc (MOH): * MOLINA HEALTHCARE TO ACQUIRE MY CHOICE WISCONSIN. * Molina Healthcare Inc (MOH) - PURCHASE PRICE FOR TRANSACTION IS APPROXIMATELY $150 MILLION, NET OF EXPECTED TAX BENEFITS AND REQUIRED REGULATORY CAPITAL. * MOLINA HEALTHCARE INC SAYS TRANSACTION IS EXPECTED TO BE IMMEDIATELY ACCRETIVE TO MOLINA'S ADJUSTED EARNINGS PER SHARE.

  13. Show article details.

    Molina Healthcare to Acquire My Choice Wisconsin

    Business Wire – 4:15 PM ET 07/13/2022

    Transaction Expands Molina’s Medicaid Managed Long-Term Care Presence into Wisconsin Molina Healthcare, Inc. (MOH) announced today that it has entered into a definitive agreement to acquire substantially all the assets of My Choice Wisconsin. MCW is a Medicaid managed care organization serving members across Wisconsin.

  14. Show article details.

    Death Cross Looms Over Molina Healthcare Investors

    Benzinga – 11:24 AM ET 06/24/2022

    If history is any guide, there may be trouble ahead for shares of Molina Healthcare. A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions.

  15. Show article details.

    Benzinga's Top Ratings Upgrades, Downgrades For June 17, 2022

    Benzinga – 11:10 AM ET 06/17/2022

    TD Securities upgraded the previous rating for AT&T Inc from Hold to Buy. B of A Securities upgraded the previous rating for The AZEK Co Inc from Neutral to Buy. Baird upgraded the previous rating for M&T Bank Corp from Neutral to Outperform. For Fifth Third Bancorp, Baird upgraded the previous rating of Neutral to Outperform.

  16. Show article details.

    Where Molina Healthcare Stands With Analysts

    Benzinga – 11:02 AM ET 06/17/2022

    Molina Healthcare has observed the following analyst ratings within the last quarter: These 4 analysts have an average price target of $314.25 versus the current price of Molina Healthcare at $253.07, implying upside. Below is a summary of how these 4 analysts rated Molina Healthcare over the past 3 months.

  17. Show article details.

    Sony, Honda sign JV to sell electric cars by 2025

    Reuters – 10:59 PM ET 06/16/2022

    - Japan's Sony (SONY) and Honda Motor (HMC) on Thursday officially agreed to an equally owned joint venture that will start selling electric cars in 2025. Honda (HMC), like bigger rival Toyota Motor (TM), has been slower to shift to electric vehicles than global automakers and is under pressure from investors to make cars that are carbon-free and equipped with newer technology such as self-driving features.

  18. Show article details.

    Sony, Honda sign JV to sell electric cars by 2025

    Reuters – 10:58 PM ET 06/16/2022

    - Japan's Sony (SONY) and Honda Motor (HMC) on Thursday officially agreed to an equally owned joint venture that will start selling electric cars in 2025. Honda (HMC), like bigger rival Toyota Motor (TM), has been slower to shift to electric vehicles than global automakers and is under pressure from investors to make cars that are carbon-free and equipped with newer technology such as self-driving features.

  19. Show article details.

    Sony, Honda sign JV to sell electric cars by 2025

    Reuters – 10:55 PM ET 06/16/2022

    Japan's Sony (SONY) and Honda Motor (HMC) on Thursday officially agreed to an equally owned joint venture that will start selling electric cars in 2025. Honda (HMC), like bigger rival Toyota Motor (TM), has been slower to shift to electric vehicles than global automakers and is under pressure from investors to make cars that are carbon-free and equipped with newer technology such as self-driving features.

  20. Show article details.

    Molina Healthcare Announces Second Quarter 2022 Earnings Release and Conference Call Dates

    Business Wire – 4:15 PM ET 06/08/2022

    Molina Healthcare, Inc. (MOH) today announced details for the release of its results for the second quarter ended June 30, 2022. Molina Healthcare (MOH) will issue its earnings release for the second quarter 2022 after the market closes on Wednesday, July 27, 2022, and will host a conference call and webcast to discuss the earnings release on Thursday, July 28, 2022, at 8:00 a.m. Eastern Time.

Page:

Today's and Upcoming Events

  • Oct
    25

    MOH to announce Q3 earnings (Unconfirmed)

Past Events (last 90 days)

  • Jul
    27

    MOH announced Q2 earnings.

Data provided by Thomson Reuters © 2022

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.